Using the same viral shRNA and CRISPR/Cas9 techniques, we were able to successfully knock down and knock out PRDM1 in primary cultured pCCa-1 cervical cancer cells (Fig. 7A, B). This evidence concerns the gene PRDM1 and cervical carcinoma.